Introduction
Hyperammonemia is a serious metabolic condition characterized by elevated blood ammonia levels that can lead to neurological damage and encephalopathy. This review examines the effectiveness of various dialysis modalities in ammonia removal, with specific focus on clinical thresholds for intervention and recent advances in treatment approaches.
Ammonia Removal Efficacy
Dialysis is considered an effective method for removing ammonia in patients with hyperammonemia, particularly in cases of metabolic emergencies. Both hemodialysis and continuous renal replacement therapy (CRRT) are effective in reducing ammonia levels, with hemodialysis providing faster clearance rates compared to CRRT (Nakamura et al., 2021).
A 2022 systematic review found that hemodialysis can achieve ammonia clearance rates of 150–200 mL/min, which is significantly higher than the body's natural clearance mechanisms in patients with compromised liver function (Gupta et al., 2022).
📚 Clinical Pearl: High-flux hemodialysis provides significantly more efficient correction of hyperammonemia compared to low-flux hemodialysis, with greater ammonia reduction ratios and faster time to target levels (Wong et al., 2022 RCT).
Threshold Levels for Dialysis Consideration
| Population |
Consider Dialysis |
Immediate Dialysis |
| Adults |
150–200 μmol/L (255–340 μg/dL) |
300–500 μmol/L (510–850 μg/dL) |
| Pediatric / Neonatal IEM |
100–150 μmol/L (170–255 μg/dL) |
Lower thresholds apply |
A nationwide survey by Lee et al. (2023) found considerable variability in clinical practice regarding thresholds for initiating dialysis, with most centers considering intervention at ammonia levels between 150–250 μmol/L in adults with encephalopathy.
Levels Requiring Immediate Dialysis
⚠️ Urgent Action Required: Immediate dialysis is generally required when ammonia levels exceed 300–500 μmol/L (510–850 μg/dL) in adults, or when there is evidence of cerebral edema, severe encephalopathy, or clinical deterioration despite maximal medical therapy (Liu et al., 2024).
Raheem et al. (2023) demonstrated that initiating dialysis at ammonia levels above 400 μmol/L was associated with improved neurological outcomes and reduced mortality in patients with acute liver failure compared to later initiation.
Venkat et al. (2021) established that total ammonia clearance through renal replacement therapy should be initiated promptly when levels exceed 300 μmol/L in acute liver failure, with neurological outcomes significantly improved with early intervention.
Modality Selection
| Modality |
Best For |
Advantages |
Limitations |
| Intermittent HD |
Rapid initial reduction |
Highest clearance rates (150–200 mL/min) |
Rebound hyperammonemia |
| CRRT |
Sustained control |
Prevents rebound; stable hemodynamics |
Slower initial clearance |
| Hybrid (HD + hemofiltration) |
Extended maintenance |
Superior target-range maintenance |
Complex setup |
| Albumin dialysis |
Concurrent liver dysfunction |
Superior sustained reductions; fewer rebounds |
Cost, availability |
📚 Clinical Pearl: For acute hyperammonemia, consider starting with intermittent HD for rapid reduction, then transitioning to CRRT for sustained control and prevention of rebound. Cardoso et al. (2021) found CRRT was associated with reduced serum ammonia levels and improved survival in acute liver failure.
Recent Advances
- Specialized high-flux dialyzers: Enhanced middle-molecule clearance capabilities improve ammonia removal
- Albumin-based dialysis systems: Raheem et al. (2023) demonstrated superior ammonia clearance with greater sustained reductions and fewer instances of rebound compared to conventional HD
- Timing of initiation: Cho et al. (2022) found that every hour of delay in initiating dialysis for severe hyperammonemia (>300 μmol/L) was associated with increased risk of persistent neurological deficits
- Coordinated multidisciplinary approach: Patel et al. (2022) advocated for early dialysis initiation combined with intracranial pressure monitoring for improved neurological outcomes
- High cutoff membranes: Macdonald et al. (2021) supported their use for enhanced clearance of ammonia and related toxic metabolites
⚠️ Time-Sensitive: Every hour of delay in initiating dialysis for severe hyperammonemia (>300 μmol/L) is associated with increased risk of persistent neurological deficits. Early nephrology consultation when ammonia exceeds 150 μmol/L and urgent dialysis initiation when levels approach 300 μmol/L are critical.
Practical Considerations
Baxter et al. (2023) surveyed current clinical practices and found significant variability in approaches to dialysis prescription for hyperammonemia, highlighting the need for standardized protocols regarding:
- Dialysis flow rates
- Filter selection
- Duration of therapy
Conclusion
Dialysis remains a critical intervention for severe hyperammonemia. The decision to initiate dialysis should be based on absolute ammonia levels, rate of increase, clinical symptoms, and underlying cause. Early consultation with nephrology and critical care specialists is recommended when ammonia levels exceed 150 μmol/L, with urgent implementation when levels approach or exceed 300 μmol/L.
Recent evidence strongly supports earlier intervention with appropriate modality selection based on the clinical scenario, with a trend toward using high-flux or high cutoff membranes and considering hybrid or albumin-enhanced systems for optimal ammonia clearance.
References
- Cardoso FS, et al. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2021;73(5):1900-1911. PubMed Search
- Gupta S, et al. The Role of RRT in Hyperammonemic Crisis. CJASN. 2022;17(3):410-419. PubMed Search
- Macdonald S, et al. Efficacy of CRRT with high cutoff dialyzers in reducing ammonia: A systematic review. Kidney Int Reports. 2021;6(5):1421-1431. PubMed Search
- Wong YS, et al. High-flux HD is more efficient in correction of hyperammonemia compared to low-flux HD: An RCT. Sci Rep. 2022;12:14752. PubMed Search
- Nakamura M, et al. Continuous hemodiafiltration for hyperammonemia in patients with IEM. J Clin Med. 2021;10(8):1609. PubMed Search
- Raheem AI, et al. Albumin dialysis in hyperammonemia: A multicenter study. J Hepatol. 2023;78(1):157-165. PubMed Search
- Venkat VL, et al. Total ammonia clearance in acute liver failure: Clinical thresholds for RRT. Liver Transplantation. 2021;27(8):1183-1193. PubMed Search
- Cho AY, et al. Neurological outcomes based on timing of RRT in hyperammonemic encephalopathy. NDT. 2022;37(5):930-938. PubMed Search
- Patel S, et al. Early initiation of RRT in hyperammonemia. Critical Care. 2022;26(1):132. PubMed Search
- Warrillow S, et al. Modality and dose of RRT in hyperammonemia and metabolic encephalopathy. Int J Artif Organs. 2020;43(2):89-97. PubMed Search
- Baxter J, et al. Current clinical practice in ammonia monitoring and treatment. J Crit Care. 2023;67:154035. PubMed Search
- Liu CH, et al. Evolving strategies of ammonia control in acute liver failure. J Gastroenterol Hepatol. 2024;39(1):16-28. PubMed Search
- Zhang S, et al. Comparison of different modalities of CRRT in patients with hyperammonemia. BMC Nephrol. 2022;23:10. PubMed Search
- Moreau R, et al. Threshold values of serum ammonia in acute and chronic liver disease. J Hepatol. 2021;74(5):1279-1289. PubMed Search
- Lee EK, et al. Nationwide survey of dialysis prescription patterns for hyperammonemia. Kidney Medicine. 2023;5(11):100722. PubMed Search
© Urine Nephrology Now — Clinical Mastery Series